Terms: = Colorectal cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Prognosis
14 results:
1. Downregulation of TEX11 promotes S-Phase progression and proliferation in colorectal cancer cells through the foxo3a/COP1/c-Jun/p21 axis.
Zhang X; Hu F; Zhu B; Jiao X; Li Y; Wu S; Ren G; Li J; Xie Q; Pan Y; Li H; Zhao L
Oncogene; 2022 Nov; 41(47):5133-5145. PubMed ID: 36258021
[TBL] [Abstract] [Full Text] [Related]
2. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN.
Chong X; Chen J; Zheng N; Zhou Z; Hai Y; Chen S; Zhang Y; Yu Q; Yu S; Chen Z; Bao W; Quan M; Chen ZS; Zhan Y; Gao Y
Mol Cancer; 2022 May; 21(1):118. PubMed ID: 35619132
[TBL] [Abstract] [Full Text] [Related]
3. A Spatial and Functional Interaction of a Heterotetramer Survivin-DNA-PKcs Complex in DNA Damage Response.
Güllülü Ö; Hehlgans S; Mayer BE; Gößner I; Petraki C; Hoffmann M; Dombrowsky MJ; Kunzmann P; Hamacher K; Strebhardt K; Fokas E; Rödel C; Münch C; Rödel F
Cancer Res; 2021 May; 81(9):2304-2317. PubMed ID: 33408118
[TBL] [Abstract] [Full Text] [Related]
4. Butyrate enhances the efficacy of radiotherapy via foxo3A in colorectal cancer patient‑derived organoids.
Park M; Kwon J; Shin HJ; Moon SM; Kim SB; Shin US; Han YH; Kim Y
Int J Oncol; 2020 Dec; 57(6):1307-1318. PubMed ID: 33173975
[TBL] [Abstract] [Full Text] [Related]
5. LAMB3 promotes tumour progression through the AKT-foxo3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.
Zhu Z; Song J; Guo Y; Huang Z; Chen X; Dang X; Huang Y; Wang Y; Ou W; Yang Y; Yu W; Liu CY; Cui L
Oncogene; 2020 Jun; 39(24):4666-4680. PubMed ID: 32398865
[TBL] [Abstract] [Full Text] [Related]
6. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
[TBL] [Abstract] [Full Text] [Related]
7. SIRT6, a novel direct transcriptional target of foxo3a, mediates colon cancer therapy.
Zhang Y; Nie L; Xu K; Fu Y; Zhong J; Gu K; Zhang L
Theranostics; 2019; 9(8):2380-2394. PubMed ID: 31149050
[TBL] [Abstract] [Full Text] [Related]
8. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.
Chen F; Zhang L; Wu J; Huo F; Ren X; Zheng J; Pei D
Cell Death Dis; 2018 Dec; 9(12):1176. PubMed ID: 30518879
[TBL] [Abstract] [Full Text] [Related]
9. High expression of Ras-related protein 1A promotes an aggressive phenotype in colorectal cancer via PTEN/foxo3/CCND1 pathway.
Liu L; Yan X; Wu D; Yang Y; Li M; Su Y; Yang W; Shan Z; Gao Y; Jin Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):178. PubMed ID: 30064475
[TBL] [Abstract] [Full Text] [Related]
10. Effects of miR-223 on colorectal cancer cell proliferation and apoptosis through regulating foxo3a/BIM.
Ju H; Tan JY; Cao B; Song MQ; Tian ZB
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3771-3778. PubMed ID: 29949152
[TBL] [Abstract] [Full Text] [Related]
11. miR-182-5p promotes hepatocellular carcinoma progression by repressing foxo3a.
Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
[TBL] [Abstract] [Full Text] [Related]
12. FOXC2 promotes colorectal cancer proliferation through inhibition of foxo3a and activation of MAPK and AKT signaling pathways.
Cui YM; Jiang D; Zhang SH; Wu P; Ye YP; Chen CM; Tang N; Liang L; Li TT; Qi L; Wang SY; Jiao HL; Lin J; Ding YQ; Liao WT
Cancer Lett; 2014 Oct; 353(1):87-94. PubMed ID: 25069037
[TBL] [Abstract] [Full Text] [Related]
13. microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.
Liao WT; Li TT; Wang ZG; Wang SY; He MR; Ye YP; Qi L; Cui YM; Wu P; Jiao HL; Zhang C; Xie YJ; Wang JX; Ding YQ
Clin Cancer Res; 2013 Sep; 19(17):4662-72. PubMed ID: 23846336
[TBL] [Abstract] [Full Text] [Related]
14. SPROUTY2 is a β-catenin and foxo3a target gene indicative of poor prognosis in colon cancer.
Ordóñez-Morán P; Irmisch A; Barbáchano A; Chicote I; Tenbaum S; Landolfi S; Tabernero J; Huelsken J; Muñoz A; Pálmer HG
Oncogene; 2014 Apr; 33(15):1975-85. PubMed ID: 23624922
[TBL] [Abstract] [Full Text] [Related]
